Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
67 Total results for product and free and sample content found
Scrip
26 Mar 2021
Access Asia Pharma Intelligence expertise and hear from Pharma journalists across Asia to reveal deep regional expertise with this sample of Scrip's Asia 100 Report.
Topic Business Strategies China Company Analysis Drug Development Landscape Market Intelligence
Scrip
27 Nov 2020
The RECOVERY trial has produced clear results for the cheap steroid treatment dexamethasone. What does it mean for Gilead's antiviral remdesivir?
Scrip
27 Nov 2020
Sanofi’s €610m investment helps row to be forgotten – though Macron will ‘place bets’ on several COVID-19 vaccines, not just France’s homegrown candidate.
Topic Coronavirus Company Analysis
Scrip
16 Jul 2020
The annual “Scrip Asia 100”, the highly anticipated financial performance ranking of pharma companies headquartered in the APAC region, is coming soon. Don’t miss your opportunity to position yourself as a leader in APAC pharma with a sponsorship in this indispensable publication.
Scrip
06 Jul 2020
CEO pay at the top 15 pharma companies increased by 3.9% in 2019. But how did that match up to company performance? Read the article now available from Scrip and learn who were the big winners, and how their companies performed financially.
Medtech Insight
20 Apr 2020
Now more than ever, staying on top of the shifting dynamics of the medtech market is critical. Medtech Insight takes you inside recent company results for your view into the health and market landscape of medtech as we enter an unprecedented era.
Scrip
By Andrew McConaghie 30 Jan 2020
The Coalition for Epidemic Preparedness Innovations adds new deal with mRNA specialist Moderna for rapid development of coronavirus vaccine.
Topic Company Analysis Coronavirus Infectious Diseases Vaccines
Scrip
06 Dec 2019
Cipla’s global chief operating officer is leaving the company to pursue new interests, amid a spate of top-level exits that have marked the pharma sector in India in 2019.
Topic Leadership Company Analysis
HBW Insight
By David Ridley 13 Nov 2019
Following a landmark win against the German government for the Rx-to-OTC switch of desloratadine last month, Novartis has again secured a victory in the German Higher Court system, this time to continue marketing its Biosan probiotics range in the country.
No Records Found
Request a live demo
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Speak to Sales
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Client Services
Contact us for product technical and account support.
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
